Oncology companies

Kronos Bio is dedicated to the research and development of first-in-class therapies that modulate historically recalcitrant cancer targets.

Instil Bio (formerly Immetacyte, Cellular Therapeutics) is an immuno-oncology company that specializes in cell therapies.

bioAffinity Technologies is a company focusing on the diagnosis of early-stage cancer, diseases of the lung, and targeted cancer treatment.

Xilio Therapeutics (formerly Akrevia Therapeutics) is a biopharmaceutical company focused on developing targeted immuno-oncology therapeutics.

Rain Therapeutics is a biotechnology company focused on developing small molecule targeted therapeutics for cancer patients.

BRIM Biotechnology (全福生物科技股份有限公司) is a company that develops drugs for oncology and infectious disease.

Achieve Life Sciences is a biopharmaceutical company that develops and commercializes therapies that address treatment resistance in cancer patients.

Gamida Cell develops stem cell therapy technologies and products for the treatment of blood cancers, autoimmune and metabolic diseases.

Monopar Therapeutics is a biopharmaceutical company focused on developing innovative drugs and drug combinations to improve clinical outcomes for cancer patients.

Acrivon (also known as Acrivon Therapeutics) is a clinical-stage oncology company that leverages a precision medicine platform called Acrivon Predictive Precision Proteomics (AP3) for the development of a drug pipeline.

Cancer Genetics, Inc. (CGI) provides DNA-based cancer diagnostics and services to medical institutions.

Sareum Holdings discovers and develops innovative drug candidates aimed at cancers and autoimmune diseases.